US Stock Market Closed

Dashboard

MediWound Ltd. (MDWD)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

S

Analyst Opinion

S

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.

CEO

Sharon Malka

Employees

74

Industry

-

Sector

-

Headquarters

Yavne

Exchange

NASDAQ

Summary Stats

Market Cap

571M

Revenue

20.9M

Net Income

-15.4M

EPS

-$0.53

Price-to-Earnings

-26.39

Price-to-Book

-255.35

Debt-to-Equity

-10.44

News

Analyst Ratings

Price targets projected by 5 analysts

High

$7.00

Average

$6.50

Low

$5.00

Ratings calculated by 5 analysts

Buy

5

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.35

Actual

-$0.91 -62.5%

Consensus

-0.56

Report Date

Year Ago

-0.12

Year Ago Change %

Down 658%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites